F_30 D Frn

30963

Federal Register / Vol. 86, No. 110 / Thursday, June 10, 2021 / Notices
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021–12150 Filed 6–9–21; 8:45 am]
BILLING CODE 4165–15–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–0990–XXXX]

Agency Information Collection
Request; 30-Day Public Comment
Request

utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Family
Planning Annual Report 2.0.
Type of Collection: New.
OMB No.: 0990–NEW—Office of
Population Affairs.
Abstract: The Office of Population
Affairs (OPA), within the Office of the
Assistant Secretary for Health, seeks
approval for a new 3-year encounter
level data collection for the Family
Planning Annual Report (FPAR).
Currently collected in aggregate under
OMB No. 0990–0221, this new data
collection, ‘‘FPAR 2.0’’, will collect
information at the encounter level and
build on the existing data collection and
reporting system. This annual reporting
requirement is for competitively
awarded grants authorized and funded
by the Title X Family Planning Program.

Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before July 12, 2021.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT:
Sherrette Funn, [email protected]
or (202) 795–7714. When submitting
comments or requesting information,
please include the document identifier
0990–New–30D and project title for
reference.
Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and

SUPPLEMENTARY INFORMATION:

Office of the Secretary, HHS.
ACTION: Notice.
AGENCY:

In compliance with the
requirement of the Paperwork

SUMMARY:

ESTIMATED ANNUALIZED BURDEN TABLE
Number of
respondents

Type of respondent

Average
burden per
response
(in hours)

Total
burden
hours

Grantees ..........................................................................................................

70

1

102

7140

Total ..........................................................................................................

70

1

102

7140

Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2021–12113 Filed 6–9–21; 8:45 am]
BILLING CODE 4150–34–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections

khammond on DSKJM1Z7X2PROD with NOTICES

Number
responses per
respondent

VerDate Sep<11>2014

19:52 Jun 09, 2021

Jkt 253001

PO 00000

Frm 00054

Fmt 4703

Sfmt 4703

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Clinical Trials SEP (UG3, U24, R61, R34).
Date: July 21, 2021.

E:\FR\FM\10JNN1.SGM

10JNN1